Globe Life Faces Investigation After Disclosing $7 Million in Excess CMS-Linked Claims
· GlobeWire Daily Business Desk · Source: www.prnewswire.com

Original GlobeWire Daily editorial illustration — not an event photograph.
An ongoing legal investigation is examining Globe Life Inc. following the disclosure of approximately $7 million in excess prior-period Medicare Supplement claims. The reported figures and subsequent stock movement have prompted inquiries by legal representation regarding disclosures made to shareholders.
Financial Disclosures and Stock Response
Globe Life reported approximately $7 million in excess Medicare Supplement claims from prior periods, which were paid following a processing delay at the Centers for Medicare & Medicaid Services (CMS). These items appeared within the third-quarter results for the period ended September 30, 2026. Following the October 22, 2026 disclosure, Globe Life shares dropped by more than 8% on October 23, 2026.
Key financial highlights reported for the quarter include:
- United American Division: The division writing Medicare Supplement coverage reported a health underwriting margin of negative $6 million on $219 million in health premiums.
- Growth Metrics: Health premiums rose 29% year over year, while health sales climbed 95% to reach $48 million.
Investigation Focus
SueWallSt, powered by Levi & Korsinsky LLP, has announced a pending investigation into potential securities law violations. The inquiry centers on whether Globe Life adequately disclosed its exposure to CMS claims-processing changes and its claims experience prior to the third-quarter report.
- Eligibility: Investors who purchased Globe Life (NYSE: GL) stock and suffered financial losses may be eligible to request a review.
- Costs and Requirements: Submissions for evaluation involve no upfront cost, and legal representation in such matters is generally handled on a contingency basis subject to court approval. Most participating investors do not need to make court appearances or give depositions.
Practical Implications and Verification
Investors experiencing losses can verify original disclosures through official regulatory filings submitted to the U.S. Securities and Exchange Commission (SEC) or via Globe Life's investor relations announcements published on October 22, 2026. To participate in evaluations or review potential recovery options, investors can gather brokerage statements, trade confirmations, and records showing purchase dates, share quantities, and prices paid.
AI-assisted reporting; source claims are attributed and have not been independently verified.



